Author

Jordi Faraudo

Institut de Ciència de Materials de BarcelonaORCID 0000-0002-6315-4993Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biophysics· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1 Approach:simulation· 1

Frequent Co-Authors

Huixia LuiD· 3 shared Jordi Martı́iD· 3 shared Buyong MaiD· 1 shared Honglin XuiD· 1 shared Zheyao HuiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiophysics

Huixia LuORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

KRAS recognition by Src: Mechanistic insights from Molecular Dynamics Simulations

Huixia Lu, Honglin Xu, Jordi Marti, Buyong Ma, Jordi Faraudo

This study uses molecular dynamics simulations to uncover how c-Src recognizes and phosphorylates different forms of KRas, identifying key residues and conformations involved in this interaction.

bioRxiv · Oct 14, 2026 · PreprintBiophysics

Probing the Structural Dynamics of the Unbound MAX Protein: Insights from Well-Tempered Metadynamics

Huixia Lu, Jordi Marti, Jordi Faraudo

This study uses well-tempered metadynamics to explore the conformational space of unbound MAX protein, revealing a stable structure and potential druggable sites for targeting MYC/MAX interactions.

Journal of Chemical Information and Modeling · Dec 28, 2025Peer-reviewedBiophysics

Discovery of a new drug using lipid-based formulation targeting G12D mutated KRAS4B through non-covalent bonds

Huixia Lu, Zheyao Hu, Jordi Faraudo, Jordi Martı́

This paper describes the design of a lipid-based drug, LIG1, that targets KRAS4B-G12D and phosphodiesterase-delta to inhibit cancer cell proliferation.

bioRxiv · Apr 5, 2023 · PreprintMolecular Biology